FILIP JANKU to Gastrointestinal Stromal Tumors
This is a "connection" page, showing publications FILIP JANKU has written about Gastrointestinal Stromal Tumors.
Connection Strength
1.734
-
Ripretinib intrapatient dose escalation after disease progression provides clinically meaningful outcomes in advanced gastrointestinal stromal tumour. Eur J Cancer. 2021 09; 155:236-244.
Score: 0.649
-
Switch Control Inhibition of KIT and PDGFRA in Patients With Advanced Gastrointestinal Stromal Tumor: A Phase I Study of Ripretinib. J Clin Oncol. 2020 10 01; 38(28):3294-3303.
Score: 0.606
-
Unusual presentation of gastrointestinal stromal tumor with early cerebral involvement. Ir J Med Sci. 2011 Sep; 180(3):765-6.
Score: 0.306
-
Efficacy and safety of ripretinib in patients with KIT-altered metastatic melanoma. ESMO Open. 2022 08; 7(4):100520.
Score: 0.172